Tepoxalin
![]() | |
![]() | |
Systematic (IUPAC) name | |
---|---|
3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
ATCvet code | QM01AE92 (WHO) |
PubChem | CID 59757 |
ChemSpider | 53906 |
UNII |
TZ4OX61974 ![]() |
KEGG |
D06075 ![]() |
ChEBI |
CHEBI:76277 ![]() |
Chemical data | |
Formula | C20H20ClN3O3 |
Molar mass | 385.844 g/mol |
| |
| |
![]() ![]() |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use in the United States and many other countries.[1] It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.[2]
It is generally marketed under the brand name Zubrin.[1]
See also
- Ipazilide
References
|
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.